A peer-reviewed article of this Preprint also exists.
Kaneko, M. K., Suzuki, H., & Kato, Y. (2024). Establishment of a Novel Cancer-specific Anti-HER2 Monoclonal Antibody H2Mab-250/H2CasMab-2 for breast cancers. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, 43(2), 35-43.
